Insider Transaction Report for ARS Pharmaceuticals, Inc.

Alexander A. Fitzpatrick, Chief Legal Officer of ARS Pharmaceuticals, Inc. (SPRY), reported a sale of 3,355 shares of Common Stock on June 12, 2026. The transaction, executed under a Rule 10b5-1 trading plan, occurred at a price of $10.00 per share. Following this sale, Mr. Fitzpatrick owns 90,910 shares. This report also notes the acquisition of 2,907 shares under the company's Employee Stock Purchase Plan on June 30, 2025, and an additional 1,745 shares acquired under the ESPP on December 31, 2025.